Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers


Baykara M., Buyukberber S., Ozturk B., Coskun U., Kaplan M. A. , Unsal D. K. , ...Daha Fazla

TUMORI, cilt.99, sa.4, ss.469-473, 2013 (SCI İndekslerine Giren Dergi) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 99 Konu: 4
  • Basım Tarihi: 2013
  • Dergi Adı: TUMORI
  • Sayfa Sayıları: ss.469-473

Özet

Aims and background. Chemoradiation using cisplatin-based regimens has become the standard care in the treatment of nasopharyngeal cancers, The impact of taxanes as radiosensitizing agents with concurrent chemoradiation regimens is unknown. We retrospectively evaluated the efficacy and tolerability of weekly cisplatin + docetaxel combination with chemoradiation in locally advanced nasopharyngeal cancers.